Caris+ vs ASCO
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
Caris+
Access and manage your Caris profiling cases on the go. View patient results, track testing progress, and receive real-time notifications. Approve orders and explore interactive results with potential clinical trial matches.
- View and search cases
- Real-time case notifications
- Track testing progress
- Approve orders
- Interactive results
- Clinical trial matching
- Request molecular tumor board review
Read full descriptionHide full description
The Caris+ App provides convenient access to manage and review Caris profiling cases. View current and past patient results whenever and wherever you are. • View and search current and past cases • Receive real-time case notifications • Track testing progress • Approve orders • View interactive results and select clinical trial matches • Request Caris Molecular Tumor Board review • Share patient educational information About Caris Life Sciences Caris Life Sciences® is a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine through quality and innovation. The company’s suite of market-leading molecular profiling offerings assesses DNA, RNA and proteins to reveal a molecular blueprint that helps physicians and cancer patients make more precise and personalized treatment decisions. Caris is also advancing precision medicine with Caris Artificial Intelligence, combining its market leading service offering, Caris Molecular Intelligence® with its proprietary artificial intelligence analytics engine, DEAN™. This information, coupled with mature clinical outcomes on thousands of patients, provides unmatched molecular solutions for patients, physicians, payers and biopharmaceutical organizations.
ASCO
Read full descriptionHide full description
The new ASCO App is a trusted tool for ASCO Members and the oncology community. Get a personalized feed of practice-changing science from JCO Journals tailored to your specialty, streamline your membership, and access professional development tools like ASCO-SEP®—anytime, anywhere. It’s an essential resource designed to save you time while fostering continuous engagement with the global oncology community.
Screenshots
Verdict
Caris+ and ASCO are too close to call on the numbers: across 6 compared parameters — price, update cadence, ads and in-app purchases among them — neither pulls far enough ahead to decide it. What separates them is feature set and interface, not measurable difference.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
Caris+ ships an update monthly, ASCO every 3 weeks. The most recent releases landed on October 4, 2026 and October 10, 2026 respectively.
| Parameter | Caris+ | ASCO |
|---|---|---|
| Price | Free | Free |
| Rating | 4.4 (7 ratings) — better | — |
| Positive reviews | 66.7% of reviews | — |
| Number of ratings | 7 — better | — |
| Update frequency | Monthly | Every 3 weeks — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | — |
| Devices | iPhone, iPad | iPhone, iPad, iPod — better |
| Requires iOS | 16.0 | 16 |
| Further details — not scored | ||
| Size | 23 MB | 59 MB |
| Age rating | 17+ | 17+ |
| Developer | Caris MPI, Inc. | American Society of Clinical Oncology |
In-app purchases
Caris+
No in-app purchases
ASCO
No in-app purchases









